Syeda Mahrukh Hussnain Naqvi
Overview
Explore the profile of Syeda Mahrukh Hussnain Naqvi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yuan Z, Frazer M, Ahmed K, Naqvi S, Schell M, Felder S, et al.
Future Oncol
. 2020 Jul;
16(30):2411-2420.
PMID: 32686956
Genomic-based risk stratification to personalize radiation dose in rectal cancer. We modeled genomic-based radiation dose response using the previously validated radiosensitivity index (RSI) and the clinically actionable genomic-adjusted radiation dose....
12.
Burke E, Laronga C, Sun W, DeBiase S, Naqvi S, Fridley B, et al.
Clin Breast Cancer
. 2019 Nov;
20(1):e14-e19.
PMID: 31780380
Introduction: Implant-sparing mastectomy (ISM) is a skin-sparing mastectomy that preserves a retropectoral implant and potentially eliminates the need for tissue expansion or complex reconstruction. This study aimed to determine oncologic...
13.
Eroglu Z, Eatrides J, Naqvi S, Kim Y, Rich J, Babacan N, et al.
Pigment Cell Melanoma Res
. 2019 Jul;
33(1):86-95.
PMID: 31329344
Current management of locoregional and oligometastatic melanoma is typically with surgery; however, some patients are unable to undergo resection due to location/size of their tumors and/or the anticipated morbidity of...
14.
Naqvi S, Kim Y
Transl Lung Cancer Res
. 2019 May;
8(2):116-118.
PMID: 31106121
No abstract available.
15.
Miura J, Kroon H, Beasley G, Mullen D, Farrow N, Mosca P, et al.
Ann Surg Oncol
. 2019 Mar;
26(8):2486-2494.
PMID: 30911949
Background: Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose regional chemotherapy to patients with locally advanced or in-transit melanoma located on a limb. The current international...
16.
Baz R, Naqvi S, Lee J, Brayer J, Hillgruber N, Fridley B, et al.
Br J Haematol
. 2018 Dec;
184(5):735-743.
PMID: 30548250
Combined lenalidomide and dexamethasone is a standard-of-care therapy for the treatment of older adults with multiple myeloma. Lenalidomide monotherapy has not been evaluated in newly diagnosed myeloma patients. We conducted...
17.
Perez M, Miura J, Naqvi S, Kim Y, Holstein A, Lee D, et al.
Ann Surg Oncol
. 2018 Oct;
25(13):3960-3965.
PMID: 30298318
Background: Talimogene laherparepvec (TVEC) is an oncolytic herpes virus used as intralesional therapy for patients with unresectable stage IIIB through IV melanoma. We reviewed the standard of care treatment of...
18.
Rollison D, Schell M, Fenske N, Cherpelis B, Messina J, Giuliano A, et al.
J Infect Dis
. 2018 Sep;
219(5):711-722.
PMID: 30260406
Background: Findings from previous studies of cutaneous human papillomavirus (cuHPV) infection and keratinocyte carcinomas have varied due to several factors, including use of different sample types for cuHPV DNA detection....
19.
ODonoghue C, Perez M, Mullinax J, Hardman D, Sileno S, Naqvi S, et al.
Ann Surg Oncol
. 2017 Oct;
24(13):3842-3849.
PMID: 29019175
Background: Isolated limb infusion (ILI) is a minimally invasive technique for delivering regional chemotherapy to an extremity for patients with locally advanced cutaneous malignancies and sarcoma. Methods: A single-institution, prospectively...
20.
Sandoval-Sus J, Chavez J, Dalia S, Naqvi S, Talati C, Nodzon L, et al.
Leuk Lymphoma
. 2017 Jun;
59(1):59-68.
PMID: 28641468
Immunoglobulin heavy-chain variable region (IGHV) mutational status and karyotype abnormalities are important prognostic factors in chronic lymphocytic leukemia (CLL). The goal was to assess the impact of IGHV in CLL...